Company Search:
Advanced Search
Sponsored Links
Oxford BioMedica plc Company Snapshot
Oxford BioMedica plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oxford BioMedica plc with three other companies in this sector in the United Kingdom: Vernalis Plc (2015 sales of £13.25 million [US$16.16 million] of which 100% was Pharmaceutical), Puricore PLC (£15.35 million [US$18.72 million] of which 95% was Supermarket Retail), and Cyprotex PLC (£15.61 million [US$19.04 million] of which 100% was In Vitro & In Silic).

Sales Analysis. During the year ended December of 2015, sales at Oxford BioMedica plc were £15.91 million (US$19.40 million). This is an increase of 16.8% versus 2014, when the company's sales were £13.62 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oxford BioMedica plc
  Stock Performance Chart for Oxford BioMedica plc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 3.16p
(Figures in Pounds Sterling)
1 Week 0.3%   13 Weeks -5.5%  
4 Weeks -22.5%   52 Weeks -52.1%  
Oxford BioMedica plc Key Data:
  Ticker: OXB Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 15,909,000
(Year Ending Jan 2016).
Employees: 196
  Currency: Pounds Sterling Market Cap: 85,425,687
  Fiscal Yr Ends: December Shares Outstanding: 2,703,344,512
  Share Type: Ordinary Closely Held Shares: 522,935,951
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.